Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Nasal Spray for Mild COVID-19 Infection
2020-004994-27Phase 2Unknown
- Sponsor
- Ashford and St Peter's Hospitals NHS Foundation Trust
- Start
- Oct 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nitric oxide in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ashford and St Peter's Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
nitric oxide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-004994-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004994-27.